ImmuneWorks' Convertible Note Round

ImmuneWorks raised a round of funding on January 22, 2008.

ImmuneWorks is a clinical stage biotechnology company developing a therapeutic asset for idiopathic pulmonary fibrosis (IPF) and additional fibrotic lung diseases.…

Articles about ImmuneWorks' Convertible Note Round: